1、S-1 1 d462304ds1.htm S-1Table of ContentsAs filed with the U.S.Securities and Exchange Commission on March 29,2023.Registration No.333-UNITED STATESSECURITIES AND EXCHANGE COMMISSIONWashington,DC 20549FORM S-1REGISTRATION STATEMENTUnderThe Securities Act of 1933Heart Test Laboratories,Inc.(Exact nam
2、e of registrant as specified in its charter)Texas 334510 26-1344466(State or other jurisdiction ofincorporation or organization)(Primary Standard IndustrialClassification Code Number)(I.R.S.EmployerIdentification Number)Danielle Watson550 Reserve St,Suite 360 550 Reserve St,Suite 360Southlake,Texas
3、76092 Southlake,Texas 76092682-237-7781 682-237-7781(Address,including zip code,and telephone number,including area code,of registrantsprincipal executive offices)(Name,address,including zip code,and telephone number,including area code,of agent forservice)Copies to:Richard F.Dahlson Noah SpeckJacks
4、on Walker LLP Jackson Walker LLP2323 Ross Avenue 1401 McKinney StreetSuite 600 Suite 1900Dallas,Texas 75201-2725 Houston,Texas 77010214-953-6000 713-752-4200Approximate date of commencement of proposed sale to the public:As soon as practicable after the effective date of this Registration Statement.
5、If any of the securities being registered on this form are to be offered on a delayed or continuous basis pursuant to Rule 415 under the Securities Act of 1933 check the followingbox.If this Form is filed to register additional securities for an offering pursuant to Rule 462(b)under the Securities A
6、ct,please check the following box and list the Securities Actregistration statement number of the earlier effective registration statement for the same offering.If this Form is a post-effective amendment filed pursuant to Rule 462(c)under the Securities Act,check the following box and list the Secur